Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Income from Continuing Operations came in at 20846000.0 in Q1 2026, down 29.87% YoY from 29722863.03 in Q1 2025, and down 199.47% on a QoQ basis from 6961000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Income from Continuing Operations data on file, last reported at 20846000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 29.87% year-over-year to 20846000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 61707000.0 (down 15.08% YoY) and the FY2025 annual result came in at 108048000.0, down 13.84% from the prior year.
- Income from Continuing Operations declined to 20846000.0 in Q1 2026, from 6961000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 873000.0 in Q4 2024 to a low of 34890000.0 in Q1 2022.
- A 5-year average of 14718235.29 and a median of 15380000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 93.94% — and 2025, when it sank 697.37%.
- Tracing TMCI's Income from Continuing Operations over 5 years: stood at 4055000.0 in 2022, then slumped by 57.26% to 6377000.0 in 2023, then soared by 86.31% to 873000.0 in 2024, then slumped by 697.37% to 6961000.0 in 2025, then plunged by 199.47% to 20846000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 20846000.0 (Q1 2026), 6961000.0 (Q4 2025), and 16380000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn | -16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.47 Mn |
| Mar 31, 2026 | -20.85 Mn |
| Dec 31, 2025 | -6.96 Mn |
| Sep 30, 2025 | -16.38 Mn |
| Jun 30, 2025 | -17.52 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Dec 31, 2024 | -873,000.00 |
| Sep 30, 2024 | -15.38 Mn |
| Jun 30, 2024 | -21.32 Mn |
| Mar 31, 2024 | -18.75 Mn |
| Dec 31, 2023 | -6.38 Mn |
| Sep 30, 2023 | -17.54 Mn |
| Jun 30, 2023 | -12.37 Mn |
| Mar 31, 2023 | -13.58 Mn |
| Dec 31, 2022 | -4.06 Mn |
| Sep 30, 2022 | -12.09 Mn |
| Jun 30, 2022 | -15.23 Mn |
| Mar 31, 2022 | -34.89 Mn |
| Dec 31, 2021 | -6.62 Mn |
| Sep 30, 2021 | -199.46 Mn |